Research examines proteins for early breast cancer detection
|
 |
Category: ResearchType: News
Source: PNNL
Date: Friday, October 28th, 2011
October 28, 2011 
NEWS TIPS
Researchers at the D.O.E.'s Pacific Northwest National Lab are honoring October, National Breast Cancer Awareness Month, by continuing their search for better ways to detect and treat breast cancer.
Biomarkers could hold key to early detection of breast cancer
A comprehensive, collaborative research plan is looking for protein biomarkers that can be used for early breast cancer detection with blood tests. Current detection methods - including mammograms and self-exams - typically find breast cancer after it's established. The goal is to find a method to diagnose cancer before it can grow. The plan has employed advanced mass spectrometry techniques and a novel proteomics process to discover potential biomarkers. The researchers have narrowed their list from in excess of 2,000 proteins of interest to just 200 promising candidates. The suspect biomarker proteins were found in breast tissue and a liquid called nipple aspirate fluid, which is secreted by the ducts in female breasts. To identify the potential biomarkers, the researchers compared their own experimental data with previously published data on cancer genomes, among other methods. The 200 biomarker candidates are currently being tested and evaluated in patient blood samples. Scientists will further narrow their list of potential biomarkers so they can identify a handful of proteins to study in a clinical trial.
3 leading proteomics labs - at PNNL, the Broad Institute of MIT and Harvard University, and the Fred Hutchinson Cancer Research Center - joined forces for the project. This research is funded by Entertainment Industry Foundation's Women's Cancer Research Fund and Susan G. Komen for the Cure.
Proteins could help predict if breast cancer will spread
Scientists are exploring how breast cancer spreads and whether the hormonal changes women experience as they enter menopause could affect this process. The researchers are comparing breast tumor samples from both pre-menopausal and post-menopausal women. In some of those women, the cancer had also spread to their lymph nodes. They're identifying proteins whose concentrations were significantly different between the women whose cancer had and hadn't spread. The researchers are also comparing their findings between women who have and haven't reached menopause. In 3 years, the researchers have identified about 200 proteins as potentially being involved in the spread of breast cancer.
PNNL is collaborating with the Windber Research Institute and the Walter Reed Army Medical Center (now known as the Walter Reed National Military Center) for this project. The U.S. Department of Defense's Comprehensive Breast Care Plan funded the research.
Tags: Fundamental Science, Health Science, Biomolecular Science, Proteomics
Pacific Northwest National Lab is a D.O.E. Office of Science national Lab where interdisciplinary teams advance science and technology and deliver solutions to America's most intractable problems in energy, the environment and national security. PNNL employs 4,900 staff, has an yearly budget of nearly $1.1 billion, and has been managed by Ohio-based Battelle since the lab's inception in 1965. Follow PNNL on Facebook, LinkedIn and Twitter.
There are currently no comments for this story. Be the first to
add a comment!
Click here to add a comment about this story.
